AI assistant
Coloplast — M&A Activity 2016
Dec 20, 2016
3358_rns_2016-12-20_4f0affe6-9379-4ab3-84f5-1f607cdff83e.pdf
M&A Activity
Open in viewerOpens in your device viewer
Colloplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
Announcement No. 17/2016
20 December 2016
Coloplast A/S
Holtedam 1
3050 Humlebæk
Denmark
Tel: +45 4911 1111
www.coloplast.com
CVR-nr. 69749917
Coloplast completes acquisition of Comfort Medical, LLC
Coloplast has now completed the acquisition of Comfort Medical after receiving approval from relevant authorities.
All terms remain as stated in Coloplast's stock exchange announcement no. 13 regarding the acquisition of Comfort Medical and Coloplast confirms the previously stated guidance for the financial year 2016/17:
- The organic revenue growth guidance of 7-8% is unchanged. The growth in DKK of 5-6% is expected to be 1-2%-points higher.
- The EBIT margin guidance of 33-34% in constant exchange rates and about 33% in DKK is unchanged.
The long-term guidance of 7-9% organic growth p.a. and an EBIT margin expansion of 0.5%-1.0%-points p.a. is unchanged.
Lars Rasmussen
President & CEO
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
For further information, please contact
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tlf. 4911 1111
Ellen Bjurgert
Director, Investor Relations
Tel. 4911 1800 / 4911 3376
E-mail [email protected]
Press and the media
Maria Lindeberg
Senior Media Relations Manager
Tlf. 4911 3095
E-mail [email protected]
Website
www.coloplast.com
Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebæk
Denmark
CVR NR. 69749917
This announcement is available in a Danish and an English language version. In the event of any discrepancies, the Danish version shall prevail.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2016-12 All rights reserved.
Coloplast A/S, 3050 Humlebæk, Denmark.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Urology Care, Continence Care and Wound and Skin Care. We operate globally and employ more than 10,000 people.
2/2